HealthDecember 05, 2016

Webinar: Compounding Quality Act: Understanding its impact on compounding and outsourcing

Eric S. Kastango, BS Pharm, MBA, FASHP discusses the 2013 Drug Quality and Security Act, including regulatory changes made and the FDA’s involvement.

On November 27, 2013, President Obama signed the Drug Quality and Security Act (DQSA), legislation that contains important provisions relating to the oversight of compounding of human drugs.

In this webinar, Eric S. Kastango, MBA., BSPharm, FASHP reviews:

  • The elements of the changes made to Section 503A of the Federal Food, Drug and Cosmetic Act
  • A new section, 503B that deals with outsourcing facilities
  • The importance of learning about how FDA is planning to oversee the outsourcing industry

Access the on-demand webinar

Solutions
Simplifi 797®

Take the guesswork out of USP medication compounding compliance with a customizable, mobile, evidence-based solution.

 

Simplifi 797 provides the latest evidence-based guidance and helps navigate the complex USP Chapters 795, 797 and 800 processes to ensure inspection confidence and keep patients and staff safe.